CVS Health Corporation (CVS)
NASDAQ • Healthcare
July 2, 2026 at 20:00 UTC
About CVS Health Corporation
CVS Health Corporation (NYSE: CVS) is a U.S. healthcare company that combines insurance, pharmacy benefits, and retail pharmacy and clinic operations. In FY2025, it generated $402.1 billion in revenue. Its business spans managed care, prescription fulfillment, and consumer health products within the healthcare plans and services market.
Analyst Ratings
Fundamentals & Financials
TTM is calculated as the sum of the four most recently completed quarters. This is a standard approach when monthly or real-time data is not available.
Income Statement
Balance Sheet
Financial Highlights
Dividends History
Split History
Earnings Calendar
Technical Indicators
CVS Health Corporation's Technical Indicators Summary
CVS exhibits a robust technical picture with the stock around $104.72, trading well above its short- and long-term averages and supported by a large, positive on-balance volume. Momentum indicators are bullish — MACD is positive and RSI sits near the upper band — and ADX above 40 signals a strong, established trend. Volatility is moderate by ATR, and the classic pivot is just below current price as nearby support. Technical takeaway: strong buy — clear trend strength, positive momentum, and heavy volume underpin the bullish stance.
| Indicator | Value |
|---|---|
RSI (14) | 69.94 |
Stochastic %K (14, 3, 3) | 80.35 |
CCI (20) | 102.84 |
WPR (14) | -17.21 |
Momentum (10) | 5.56 |
MFI | 50.67 |
MACD Level (12, 26) | 3.30 |
Bollinger Bands | $94.56 - $106.90 |
ATR (14) | $2.36 (2.25%) |
ADX (14) | 43.67 |
OBV | 240,746,779 |
Classic Pivot Point | $104.15 |
Fibonacci Pivot Point | $104.15 |
Simple Moving Averages | $81.57 - $102.86(5 indicators) |
Exponential Moving Averages | $82.61 - $102.97(5 indicators) |
Get premium market insights delivered directly to your inbox.
Today's Snapshot
End-of-day levels show CVS only marginally weaker, with a -0.09% gap down from yesterday. Into the close, CVS still showed subdued interest, with volume at 0.53× its norm. CVS slips modestly as Caremark scrutiny and Medicare probes temper optimism from GLP-1 weight-management initiatives.
Trading Volume
0
vs S&P 500 Today
Moderate Outperformance
+0.24%
52-Week Position
Near highs
97%
Updated: July 2, 2026 at 20:11 UTC
Quote Summary
CVS Headlines
Retail leaders face war, inflation and AI shifts
April 10, 2026
Healthcare, AI and Consumer Stocks Under Review
April 3, 2026
StockStory flags several stocks for caution
March 24, 2026
CVS, Google Cloud unveil Health100 AI platform
March 5, 2026